It's a heterodimeric fusion protein containing soluble TGF-βRII and IL-15/IL15RαSu, which can neutralize TGF-β (inhibiting tumor progression and relieving immunosuppression) and directly activate immune cells. This evidence concerns the gene IL15 and neoplasm.